PCSK9

Protein-coding gene in the species homo sapiens

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Arlene Weintraub
February 19, 2021
FierceBiotech
Precision BioSciences' gene editing technique produced a stable lowering of PCSK9 protein and LDL cholesterol in nonhuman primates for three years, according to a study led by University of Pennsylvania researchers. The company is developing the one-time treatment as an alternative to drug treatments for familial hypercholesterolemia.
Ionis Pharmaceuticals, Inc.
November 30, 2020
www.prnewswire.com:443
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that the biopharmaceutical company AstraZeneca has initiated a Phase 2b clinical...
Ionis Pharmaceuticals, Inc.
November 13, 2020
www.prnewswire.com:443
/PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that new data for ION449, an investigational antisense medicine designed to reduce...
Amgen
November 9, 2020
www.prnewswire.com:443
/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that data from its cardiovascular (CV) portfolio will be presented at the American Heart Association (AHA)...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.